Polypragmasy at treatment of <i>H. pylori</i> infection in patients with concomitant diseases of other organs and systems. How to prevent side effects related to drug interactions?
The aim of the publication. Issues of drug interaction, side effects development at patients with combined diseases, requiring eradication treatment, are taken into account.Original positions. Being based on literature data and own experience, authors demonstrated, that drug interactions are observe...
Saved in:
Main Authors: | S. G. Burkov, N. V. Shornikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2011-05-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1415 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01) -
<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
by: V. T. Ivashkin, et al.
Published: (2012-11-01) -
Estimation of cytoprotective effect of bismuth tripotassium dicitrate on gastric mucosa at <i>H. pylori</i> eradication and long-term drug intake
by: A. V. Kononov, et al.
Published: (2014-12-01) -
Infection <i>Helicobacter pylori</i> and stomach cancer: state-of-the-art
by: A. A. Sheptulin
Published: (2012-04-01) -
Discussion of <i>Helicobacter pylori</i> infection issue in reports of the 19-th United European Gastroenterology Week
by: A. A. Sheptulin, et al.
Published: (2012-09-01)